The history of Viagra, formerly marketed by copyright, presents a fascinating case study for backers considering the healthcare arena . Despite its groundbreaking success and creation of billions in sales, the exclusivity end has opened the door for competing medications, substantially diminishing profit opportunities. This shift raises doubts abou